These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8829882)

  • 1. Implications of urinary basic fibroblast growth factor excretion in patients with urothelial carcinoma.
    Chow NH; Chang CJ; Yeh TM; Chan SH; Tzai TS; Lin JS
    Clin Sci (Lond); 1996 Feb; 90(2):127-33. PubMed ID: 8829882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of urinary ferritin excretion in patients with transitional cell carcinoma.
    Chow NH; Chang CJ; Cheng PE; Tzai TS; Huang CM; Lin JS
    Clin Sci (Lond); 1995 Jun; 88(6):701-6. PubMed ID: 7634755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer.
    Allen DK; Waters DJ; Knapp DW; Kuczek T
    J Vet Intern Med; 1996; 10(4):231-4. PubMed ID: 8819047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine.
    Chopin DK; Caruelle JP; Colombel M; Palcy S; Ravery V; Caruelle D; Abbou CC; Barritault D
    J Urol; 1993 Oct; 150(4):1126-30. PubMed ID: 7690426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Comparison with conventional urine cytologic evaluation.
    Ho KJ; Kuo SH
    Cancer; 1995 Aug; 76(3):473-8. PubMed ID: 8625129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
    Eissa S; Swellam M; Labib RA; El-Zayat T; El Ahmady O
    J Urol; 2009 Mar; 181(3):1353-60. PubMed ID: 19185322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical usefulness of urinary basic fetoprotein (BFP) in patients with urological malignancies].
    Tsujii T; Yonese J; Kojima S; Tari K; Ishii M; Seino Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):829-34. PubMed ID: 1698231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of transforming growth factor-alpha in patients with transitional cell carcinoma.
    Chow NH; Liu HS; Chang CJ; Chi YC; Tzai TS; Li EI; Lin JS
    Anticancer Res; 1998; 18(3B):2053-7. PubMed ID: 9677466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma.
    Yao WJ; Chang CJ; Chan SH; Chow NH; Cheng HL; Tzai TS; Lin SN
    Anticancer Res; 1995; 15(6B):2819-23. PubMed ID: 8669871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells.
    Inoue T; Nakanishi H; Inada K; Hioki T; Tatematsu M; Sugimura Y
    J Urol; 2001 Dec; 166(6):2134-41. PubMed ID: 11696722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive diagnosis of urothelial cancer in urine using DNA hypermethylation signatures-Gender matters.
    Köhler CU; Bonberg N; Ahrens M; Behrens T; Hovanec J; Eisenacher M; Noldus J; Deix T; Braun K; Gohlke H; Walter M; Tannapfel A; Tam Y; Sommerer F; Marcus K; Jöckel KH; Erbel R; Cantor CR; Käfferlein HU; Brüning T
    Int J Cancer; 2019 Nov; 145(10):2861-2872. PubMed ID: 31008534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unbiased enrichment of urine exfoliated cells on nanostructured substrates for sensitive detection of urothelial tumor cells.
    Wang X; Gu Y; Zhang S; Li G; Liu T; Wang T; Qin H; Jiang B; Zhu L; Li Y; Lei H; Li M; Zhang Q; Yang R; Fang F; Guo H
    Cancer Med; 2020 Jan; 9(1):290-301. PubMed ID: 31709750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy.
    O'Brien TS; Smith K; Cranston D; Fuggle S; Bicknell R; Harris AL
    Br J Urol; 1995 Sep; 76(3):311-4. PubMed ID: 7551838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary basic fetoprotein in the diagnosis and follow-up of patients with urothelial carcinoma.
    Kigure T; Wakayama Y; Satoh Y; Fujieda N; Yoshida K; Harada T
    Cancer; 1996 Apr; 77(8):1529-34. PubMed ID: 8608539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of semaphorin 3A in patients with urothelial cancer.
    Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
    Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
    Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
    Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary basic fibroblast growth factor. A biochemical marker for preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressiva.
    Kaplan F; Sawyer J; Connors S; Keough K; Shore E; Gannon F; Glaser D; Rocke D; Zasloff M; Folkman J
    Clin Orthop Relat Res; 1998 Jan; (346):59-65. PubMed ID: 9577411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma.
    Todenhöfer T; Hennenlotter J; Tews V; Gakis G; Aufderklamm S; Kuehs U; Stenzl A; Schwentner C
    Urol Oncol; 2013 Oct; 31(7):1148-54. PubMed ID: 22130125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary NMP22 as a new marker in patients with transitional cell carcinoma].
    Muzzonigro G; Minardi D; Galosi AB; Recchioni A; De Sio G; Polito M
    Arch Ital Urol Androl; 1999 Jun; 71(3):171-7. PubMed ID: 10431409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.